0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pet Parasite Prevention and Control Drugs Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-27X13371
Home | Market Reports | Health| Pharmacy
Global Pet Parasite Prevention and Control Drugs Market Research Report 2023
BUY CHAPTERS

Global Pet Parasite Prevention and Control Drugs Market Research Report 2025

Code: QYRE-Auto-27X13371
Report
February 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pet Parasite Prevention and Control Drugs Market Size

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%.

Pet Parasite Prevention and Control Drugs Market

Pet Parasite Prevention and Control Drugs Market

The global market for Pet Parasite Prevention and Control Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 9%.
This report aims to provide a comprehensive presentation of the global market for Pet Parasite Prevention and Control Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Parasite Prevention and Control Drugs.
The Pet Parasite Prevention and Control Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet Parasite Prevention and Control Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Parasite Prevention and Control Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pet Parasite Prevention and Control Drugs Market Report

Report Metric Details
Report Name Pet Parasite Prevention and Control Drugs Market
Accounted market size in 2022 $ 261 billion
Base Year 2022
Segment by Type
Segment by Application
  • Dog
  • Cat
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boehringer Ingelheim, Bayer, Zoetis, Dechra Pharmaceuticals, Chanelle Pharma, Merck Animal Health, Elanco, Virbac, Vetoquinol
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pet Parasite Prevention and Control Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pet Parasite Prevention and Control Drugs Market report?

Ans: The main players in the Pet Parasite Prevention and Control Drugs Market are Boehringer Ingelheim, Bayer, Zoetis, Dechra Pharmaceuticals, Chanelle Pharma, Merck Animal Health, Elanco, Virbac, Vetoquinol

What are the Application segmentation covered in the Pet Parasite Prevention and Control Drugs Market report?

Ans: The Applications covered in the Pet Parasite Prevention and Control Drugs Market report are Dog, Cat, Others

What are the Type segmentation covered in the Pet Parasite Prevention and Control Drugs Market report?

Ans: The Types covered in the Pet Parasite Prevention and Control Drugs Market report are Topical Medication, Injection Medication, Oral Medication

Recommended Reports

Pet Pharmaceuticals

Veterinary Diagnostics

Pet Care Products

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Topical Medication
1.2.3 Injection Medication
1.2.4 Oral Medication
1.3 Market by Application
1.3.1 Global Pet Parasite Prevention and Control Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Dog
1.3.3 Cat
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pet Parasite Prevention and Control Drugs Market Perspective (2020-2031)
2.2 Global Pet Parasite Prevention and Control Drugs Growth Trends by Region
2.2.1 Global Pet Parasite Prevention and Control Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pet Parasite Prevention and Control Drugs Historic Market Size by Region (2020-2025)
2.2.3 Pet Parasite Prevention and Control Drugs Forecasted Market Size by Region (2026-2031)
2.3 Pet Parasite Prevention and Control Drugs Market Dynamics
2.3.1 Pet Parasite Prevention and Control Drugs Industry Trends
2.3.2 Pet Parasite Prevention and Control Drugs Market Drivers
2.3.3 Pet Parasite Prevention and Control Drugs Market Challenges
2.3.4 Pet Parasite Prevention and Control Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Parasite Prevention and Control Drugs Players by Revenue
3.1.1 Global Top Pet Parasite Prevention and Control Drugs Players by Revenue (2020-2025)
3.1.2 Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Pet Parasite Prevention and Control Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pet Parasite Prevention and Control Drugs Revenue
3.4 Global Pet Parasite Prevention and Control Drugs Market Concentration Ratio
3.4.1 Global Pet Parasite Prevention and Control Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Parasite Prevention and Control Drugs Revenue in 2024
3.5 Global Key Players of Pet Parasite Prevention and Control Drugs Head office and Area Served
3.6 Global Key Players of Pet Parasite Prevention and Control Drugs, Product and Application
3.7 Global Key Players of Pet Parasite Prevention and Control Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Parasite Prevention and Control Drugs Breakdown Data by Type
4.1 Global Pet Parasite Prevention and Control Drugs Historic Market Size by Type (2020-2025)
4.2 Global Pet Parasite Prevention and Control Drugs Forecasted Market Size by Type (2026-2031)
5 Pet Parasite Prevention and Control Drugs Breakdown Data by Application
5.1 Global Pet Parasite Prevention and Control Drugs Historic Market Size by Application (2020-2025)
5.2 Global Pet Parasite Prevention and Control Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pet Parasite Prevention and Control Drugs Market Size (2020-2031)
6.2 North America Pet Parasite Prevention and Control Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pet Parasite Prevention and Control Drugs Market Size by Country (2020-2025)
6.4 North America Pet Parasite Prevention and Control Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pet Parasite Prevention and Control Drugs Market Size (2020-2031)
7.2 Europe Pet Parasite Prevention and Control Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pet Parasite Prevention and Control Drugs Market Size by Country (2020-2025)
7.4 Europe Pet Parasite Prevention and Control Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pet Parasite Prevention and Control Drugs Market Size (2020-2031)
8.2 Asia-Pacific Pet Parasite Prevention and Control Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pet Parasite Prevention and Control Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Pet Parasite Prevention and Control Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pet Parasite Prevention and Control Drugs Market Size (2020-2031)
9.2 Latin America Pet Parasite Prevention and Control Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pet Parasite Prevention and Control Drugs Market Size by Country (2020-2025)
9.4 Latin America Pet Parasite Prevention and Control Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Parasite Prevention and Control Drugs Market Size (2020-2031)
10.2 Middle East & Africa Pet Parasite Prevention and Control Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pet Parasite Prevention and Control Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Pet Parasite Prevention and Control Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Pet Parasite Prevention and Control Drugs Introduction
11.1.4 Boehringer Ingelheim Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Pet Parasite Prevention and Control Drugs Introduction
11.2.4 Bayer Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025)
11.2.5 Bayer Recent Development
11.3 Zoetis
11.3.1 Zoetis Company Details
11.3.2 Zoetis Business Overview
11.3.3 Zoetis Pet Parasite Prevention and Control Drugs Introduction
11.3.4 Zoetis Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025)
11.3.5 Zoetis Recent Development
11.4 Dechra Pharmaceuticals
11.4.1 Dechra Pharmaceuticals Company Details
11.4.2 Dechra Pharmaceuticals Business Overview
11.4.3 Dechra Pharmaceuticals Pet Parasite Prevention and Control Drugs Introduction
11.4.4 Dechra Pharmaceuticals Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025)
11.4.5 Dechra Pharmaceuticals Recent Development
11.5 Chanelle Pharma
11.5.1 Chanelle Pharma Company Details
11.5.2 Chanelle Pharma Business Overview
11.5.3 Chanelle Pharma Pet Parasite Prevention and Control Drugs Introduction
11.5.4 Chanelle Pharma Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025)
11.5.5 Chanelle Pharma Recent Development
11.6 Merck Animal Health
11.6.1 Merck Animal Health Company Details
11.6.2 Merck Animal Health Business Overview
11.6.3 Merck Animal Health Pet Parasite Prevention and Control Drugs Introduction
11.6.4 Merck Animal Health Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025)
11.6.5 Merck Animal Health Recent Development
11.7 Elanco
11.7.1 Elanco Company Details
11.7.2 Elanco Business Overview
11.7.3 Elanco Pet Parasite Prevention and Control Drugs Introduction
11.7.4 Elanco Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025)
11.7.5 Elanco Recent Development
11.8 Virbac
11.8.1 Virbac Company Details
11.8.2 Virbac Business Overview
11.8.3 Virbac Pet Parasite Prevention and Control Drugs Introduction
11.8.4 Virbac Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025)
11.8.5 Virbac Recent Development
11.9 Vetoquinol
11.9.1 Vetoquinol Company Details
11.9.2 Vetoquinol Business Overview
11.9.3 Vetoquinol Pet Parasite Prevention and Control Drugs Introduction
11.9.4 Vetoquinol Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025)
11.9.5 Vetoquinol Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Topical Medication
 Table 3. Key Players of Injection Medication
 Table 4. Key Players of Oral Medication
 Table 5. Global Pet Parasite Prevention and Control Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pet Parasite Prevention and Control Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Pet Parasite Prevention and Control Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Pet Parasite Prevention and Control Drugs Market Share by Region (2020-2025)
 Table 9. Global Pet Parasite Prevention and Control Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Pet Parasite Prevention and Control Drugs Market Share by Region (2026-2031)
 Table 11. Pet Parasite Prevention and Control Drugs Market Trends
 Table 12. Pet Parasite Prevention and Control Drugs Market Drivers
 Table 13. Pet Parasite Prevention and Control Drugs Market Challenges
 Table 14. Pet Parasite Prevention and Control Drugs Market Restraints
 Table 15. Global Pet Parasite Prevention and Control Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Pet Parasite Prevention and Control Drugs Market Share by Players (2020-2025)
 Table 17. Global Top Pet Parasite Prevention and Control Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Parasite Prevention and Control Drugs as of 2024)
 Table 18. Ranking of Global Top Pet Parasite Prevention and Control Drugs Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Pet Parasite Prevention and Control Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Pet Parasite Prevention and Control Drugs, Headquarters and Area Served
 Table 21. Global Key Players of Pet Parasite Prevention and Control Drugs, Product and Application
 Table 22. Global Key Players of Pet Parasite Prevention and Control Drugs, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Pet Parasite Prevention and Control Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Type (2020-2025)
 Table 26. Global Pet Parasite Prevention and Control Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Type (2026-2031)
 Table 28. Global Pet Parasite Prevention and Control Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Application (2020-2025)
 Table 30. Global Pet Parasite Prevention and Control Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Application (2026-2031)
 Table 32. North America Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Pet Parasite Prevention and Control Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Pet Parasite Prevention and Control Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Pet Parasite Prevention and Control Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Pet Parasite Prevention and Control Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Pet Parasite Prevention and Control Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Pet Parasite Prevention and Control Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Pet Parasite Prevention and Control Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Pet Parasite Prevention and Control Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Pet Parasite Prevention and Control Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Pet Parasite Prevention and Control Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Boehringer Ingelheim Company Details
 Table 48. Boehringer Ingelheim Business Overview
 Table 49. Boehringer Ingelheim Pet Parasite Prevention and Control Drugs Product
 Table 50. Boehringer Ingelheim Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025) & (US$ Million)
 Table 51. Boehringer Ingelheim Recent Development
 Table 52. Bayer Company Details
 Table 53. Bayer Business Overview
 Table 54. Bayer Pet Parasite Prevention and Control Drugs Product
 Table 55. Bayer Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025) & (US$ Million)
 Table 56. Bayer Recent Development
 Table 57. Zoetis Company Details
 Table 58. Zoetis Business Overview
 Table 59. Zoetis Pet Parasite Prevention and Control Drugs Product
 Table 60. Zoetis Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025) & (US$ Million)
 Table 61. Zoetis Recent Development
 Table 62. Dechra Pharmaceuticals Company Details
 Table 63. Dechra Pharmaceuticals Business Overview
 Table 64. Dechra Pharmaceuticals Pet Parasite Prevention and Control Drugs Product
 Table 65. Dechra Pharmaceuticals Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025) & (US$ Million)
 Table 66. Dechra Pharmaceuticals Recent Development
 Table 67. Chanelle Pharma Company Details
 Table 68. Chanelle Pharma Business Overview
 Table 69. Chanelle Pharma Pet Parasite Prevention and Control Drugs Product
 Table 70. Chanelle Pharma Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025) & (US$ Million)
 Table 71. Chanelle Pharma Recent Development
 Table 72. Merck Animal Health Company Details
 Table 73. Merck Animal Health Business Overview
 Table 74. Merck Animal Health Pet Parasite Prevention and Control Drugs Product
 Table 75. Merck Animal Health Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025) & (US$ Million)
 Table 76. Merck Animal Health Recent Development
 Table 77. Elanco Company Details
 Table 78. Elanco Business Overview
 Table 79. Elanco Pet Parasite Prevention and Control Drugs Product
 Table 80. Elanco Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025) & (US$ Million)
 Table 81. Elanco Recent Development
 Table 82. Virbac Company Details
 Table 83. Virbac Business Overview
 Table 84. Virbac Pet Parasite Prevention and Control Drugs Product
 Table 85. Virbac Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025) & (US$ Million)
 Table 86. Virbac Recent Development
 Table 87. Vetoquinol Company Details
 Table 88. Vetoquinol Business Overview
 Table 89. Vetoquinol Pet Parasite Prevention and Control Drugs Product
 Table 90. Vetoquinol Revenue in Pet Parasite Prevention and Control Drugs Business (2020-2025) & (US$ Million)
 Table 91. Vetoquinol Recent Development
 Table 92. Research Programs/Design for This Report
 Table 93. Key Data Information from Secondary Sources
 Table 94. Key Data Information from Primary Sources
 Table 95. Authors List of This Report


List of Figures
 Figure 1. Pet Parasite Prevention and Control Drugs Picture
 Figure 2. Global Pet Parasite Prevention and Control Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pet Parasite Prevention and Control Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Topical Medication Features
 Figure 5. Injection Medication Features
 Figure 6. Oral Medication Features
 Figure 7. Global Pet Parasite Prevention and Control Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Pet Parasite Prevention and Control Drugs Market Share by Application: 2024 VS 2031
 Figure 9. Dog Case Studies
 Figure 10. Cat Case Studies
 Figure 11. Others Case Studies
 Figure 12. Pet Parasite Prevention and Control Drugs Report Years Considered
 Figure 13. Global Pet Parasite Prevention and Control Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Pet Parasite Prevention and Control Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Pet Parasite Prevention and Control Drugs Market Share by Region: 2024 VS 2031
 Figure 16. Global Pet Parasite Prevention and Control Drugs Market Share by Players in 2024
 Figure 17. Global Top Pet Parasite Prevention and Control Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Parasite Prevention and Control Drugs as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Pet Parasite Prevention and Control Drugs Revenue in 2024
 Figure 19. North America Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Pet Parasite Prevention and Control Drugs Market Share by Country (2020-2031)
 Figure 21. United States Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Pet Parasite Prevention and Control Drugs Market Share by Country (2020-2031)
 Figure 25. Germany Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Pet Parasite Prevention and Control Drugs Market Share by Region (2020-2031)
 Figure 33. China Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Pet Parasite Prevention and Control Drugs Market Share by Country (2020-2031)
 Figure 41. Mexico Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Pet Parasite Prevention and Control Drugs Market Share by Country (2020-2031)
 Figure 45. Turkey Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Boehringer Ingelheim Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2020-2025)
 Figure 49. Bayer Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2020-2025)
 Figure 50. Zoetis Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2020-2025)
 Figure 51. Dechra Pharmaceuticals Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2020-2025)
 Figure 52. Chanelle Pharma Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2020-2025)
 Figure 53. Merck Animal Health Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2020-2025)
 Figure 54. Elanco Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2020-2025)
 Figure 55. Virbac Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2020-2025)
 Figure 56. Vetoquinol Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2020-2025)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

RELATED REPORTS

Global Multi-use Capsule-based Dry Powder Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O16568
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Jet Lag Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0R20253
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ruxolitinib Phosphate Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3G16891
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global NaSSAs Antidepressants Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4B16895
Thu Sep 25 00:00:00 UTC 2025

Add to Cart